TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer - Fagerholm, Rainer; Brenner, Hermann (OncoTarget, 2017)
Gesehen am 27.04.2017